Gandamon, Cherelyn S.

HRN: 27-19-51  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2025
CEFUROXIME 1.5GM (VIAL)
08/02/2025
08/03/2025
IVT
1.5
Q8
S/P LTCS With BTL
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: